Physician profile
Ranice Verchick
NPI 1447849377
$734.77
in general payments reported to CMS, 2019-2025
8 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.62 · 2023: $576 · 2024: $38.30 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $361.34 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbvie INC. | $180.84 | 2023-2025 | |
| Integra Lifesciences Corporation | $95.98 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Galderma Laboratories, L.P. | $31.21 | 2021-2023 | |
| Convatec INC. | $19.55 | 2025 | |
| Stryker Corporation | $18.03 | 2024 | Na |
| Solventum Corporation | $14.68 | 2025 | Promogran Prisma, V.A.C. Dermatac, Activ.A.C. |
| Kci USA, INC. | $13.14 | 2023 | Prevena, Activ.A.C., V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranice Verchick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.